NCT07417839

Brief Summary

Goal To compare the effectiveness of a toy nebulizer versus distraction cards in reducing fear among children during nebulization therapy while improving parental satisfaction. Aim To evaluate and measure children's fear levels and parents' satisfaction when using toy nebulizers compared to distraction cards in nebulization sessions. Null hypothesis: (Hᴏ) There is no statistically significant difference in fear levels among children, and parental satisfaction scores in in the toy nebulizer, distraction cards, and control groups. Alternative hypothesis: (H₁) There is a statistically significant difference in fear levels among children, and parental satisfaction scores in the toy nebulizer, distraction cards, and control groups.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Apr 2026Aug 2026

First Submitted

Initial submission to the registry

February 6, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

April 8, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

February 6, 2026

Last Update Submit

March 18, 2026

Conditions

Keywords

"nebulization therapy""fear""distraction card"

Outcome Measures

Primary Outcomes (2)

  • Parental Satisfaction scale

    The one-dimensional PSS is a self-administered questionnaire consisting of 11 statements or items.Each statement had five Likert scale responses ranging from one to four with score 1 representing strongly disagree and score 5 representing strongly agree. Higher scores indicate higher level of satisfaction on the interpersonal relationship with professional. The respondents were asked to choose one best response for each statement.

    9 month

  • Children's Emotional Manifestation Scale

    Children's Emotional Manifestation Scale: instruction Observe the child's behaviour throughout the entire medical procedure. Once the procedure is finished, immediately select in each category the number that most closely describes the observed behaviour during the procedure. Always refer back to the operational definition when you have difficulty or are unclear in rating the child's behaviour. Each category is scored on a 1-5 scale, resulting in a total score of 5 -25. These child behaviours will determine the extent of their fear of nebulizer.

    9 month

Study Arms (2)

Distraction Card

EXPERIMENTAL
Behavioral: distraction card

toy

EXPERIMENTAL
Behavioral: Nebuliser toy

Interventions

Set of 3-6 colorful picture cards featuring engaging images (animals, counting games, hidden objects) held 12-18 inches from the child's face during nebulization. Nurse flips cards every 1-2 minutes while prompting interactive questions (e.g., "How many stars?" or "Find the bear") to cognitively distract the child aged 3-6 from the mask, promoting calm breathing over 10-15 minute sessions (3x/week for 4 weeks). Used as non-physical, passive distraction in the control arm.

Distraction Card
Nebuliser toyBEHAVIORAL

Children aged 3-6 receive nebulization therapy using an interactive toy nebulizer (animal-shaped mask with playful features like a blow-out tongue). Nurse guides play-based breathing games during 10-15 minute sessions (3x/week for 4 weeks) to reduce fear while delivering medication.

toy

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \. Presence of at least one parent (preferably the mother) during the procedure who is capable of evaluation and communication in Arabic or Kurdish.
  • \. Children who are alert and able to cooperate (absence of severe pain or any condition preventing basic communication).
  • \. Voluntary written informed consent obtained from the parents and assent from the child (where applicable).

You may not qualify if:

  • \. Children with cognitive, neurological, or developmental disabilities, or severe chronic illnesses (e.g., terminal cancer).
  • \. Parental inability to complete fear or satisfaction questionnaires due to disability or illiteracy.
  • \. Refusal to participate by the child or parent, or the presence of emergency conditions requiring immediate life-saving intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Ibn Al Atheer

Baghdad, Mousl, 41001, Iraq

Location

Related Publications (2)

  • Nik Adib NA, Ibrahim MI, Ab Rahman A, Bakar RS, Yahaya NA, Hussin S, Nor Arifin W. Translation and validation of the Malay version of the parents' satisfaction scale (PSS-M) for assessment of caregivers' satisfaction with health care services for children with autism spectrum disorder. International journal of environmental research and public health. 2018 Nov;15(11):2455.

    BACKGROUND
  • Li HC, Lopez V. Children's Emotional Manifestation Scale: development and testing. Journal of Clinical Nursing. 2005 Feb;14(2):223-9.

    BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 6, 2026

First Posted

February 18, 2026

Study Start

April 8, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

March 23, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations